Top compounds associated with response to LRRC26


Feature Type Standardized
Nominal ANOVA
mRNA YL54 CTRPv2 pan-cancer AAC 0.047 0.2
mRNA SR8278 CTRPv2 pan-cancer AAC 0.19 0.2
mRNA ATRA CTRPv2 pan-cancer AAC 0.043 0.2
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.04 0.2
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.046 0.2
mRNA BRD-K20514654 CTRPv2 pan-cancer AAC -0.056 0.2
mRNA MLN4924 CTRPv2 pan-cancer AAC -0.04 0.3
mRNA SB-743921 CTRPv2 pan-cancer AAC 0.039 0.3
mRNA TPCA-1 CTRPv2 pan-cancer AAC -0.038 0.3
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.036 0.3
Download CSV